Methotrexat

Literatur

• 1 American College of Rheumatology ad hoc committee on clinical guidelines . Guidelines for monitoring drug therapy in rheumatoid arthritis.  Arthritis Rheum. 1996;  39 723-731
• 2 Andersen L S, Hansen E L, Knudsen J B, Wester J U, Hansen G V, Hansen T M. Prospectively measured red cell folate levels in methotrexate treated patients with rheumatoid arthritis: Relation to withdrawal and side effects.  J Rheumatol. 1997;  24 830-837
• 3 Bressole F, Kinowski J M, Morel J, Pouly B, Sany J, Combe B. Folic acid alters methotrexate availability in patients rheumatoid arthritis.  J Rheumatol. 2000;  27 2110-2114
• 4 Buckley L M. Reply.  J Rheumatol. 1996;  23 403-404
• 5 Joyce D A, Will R K, Hoffmann D M, Laing B, Blackbourn S J. Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid.  Ann Rheum Dis. 1991;  50 913-914
• 6 Ortiz Z, Shea B, Suarez A, lmazor  M, Moher D, Wells G, Tugwell P. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.  Cochrane Database Syst Rev. 2000;  2 CD000951
• 7 Schröder F, Schroeder J O. Methotrexat.  Dtsch Med Wschr. 2000;  125 1435-1436
• 8 Smolen J S, Emery P. Efficacy and safety of leflunomide in active rheumatoid arthritis.  Rheumatology. 2000;  39 48-56 (Suppl 1))